116 related articles for article (PubMed ID: 22689106)
1. [A screening program for colorectal cancer in Chilean subjects aged fifty years or more].
López-Köstner F; Kronber U; Zárate AJ; Wielandt AM; Pinto E; Suazo C; Orellana P; Avendaño R; Bresky G; Castillo M; Lubascher J; Karelovic S; Ross M; Ocares M; Riquelme F; Contreras L; Vargas B; Cortés M
Rev Med Chil; 2012 Mar; 140(3):281-6. PubMed ID: 22689106
[TBL] [Abstract][Full Text] [Related]
2. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
Trials; 2015 Jul; 16():296. PubMed ID: 26156248
[TBL] [Abstract][Full Text] [Related]
3. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
Webendörfer S; Riemann JF
Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
[TBL] [Abstract][Full Text] [Related]
4. [Results of a multicentric colorectal cancer screening program in Chile].
López-Kostner F; Zárate AJ; Ponce A; Kronberg U; Kawachi H; Okada T; Tsubaki M; Ito T; Nishikage T; Tanaka K; Kawano T; Eishi Y; Peñaloza P; Estela R; Karelovic S; Flores S
Rev Med Chil; 2018 Jun; 146(6):685-692. PubMed ID: 30148899
[TBL] [Abstract][Full Text] [Related]
5. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
6. Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: modeling the impact on colonoscopy requirements and cancer detection rates.
Olynyk JK; Platell CF; Collett JA
J Gastroenterol Hepatol; 2001 Apr; 16(4):389-92. PubMed ID: 11354276
[TBL] [Abstract][Full Text] [Related]
7. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
8. What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences.
Ventura L; Zappa M; Carreras G; Ciatto S; Grazzini G
Tumori; 2011; 97(5):547-50. PubMed ID: 22158481
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
10. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic study from a colorectal cancer screening in Chile: results from the first 2 years of an international collaboration between Chile and Japan.
Kobayashi M; Kawachi H; Pasternak S; Delgado C; Pinto P; Ito T; Karelovic S; Carrasco H; Tanaka K; Okada T; Odagaki T; Zárate AJ; Ponce A; Kronberg U; López-Köstner F; Tsubaki M; Kawano T; Eishi Y
Eur J Cancer Prev; 2019 Jul; 28(4):245-253. PubMed ID: 29958195
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer screening in LHU4 Chiavarese, Italy: ethical, methodological and outcome evaluations at the end of the first round.
Ferrari Bravo M; De Conca V; Devoto GL; Sironi M; Mele R; Fumagalli A; Rimassa P; Rossi G; Zampogna A; Sticchi C; Gabutti G;
J Prev Med Hyg; 2012 Mar; 53(1):37-43. PubMed ID: 22803318
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results.
Grazzini G; Castiglione G; Ciabattoni C; Franceschini F; Giorgi D; Gozzi S; Mantellini P; Lopane P; Perco M; Rubeca T; Salvadori P; Visioli CB; Zappa M
Eur J Cancer Prev; 2004 Feb; 13(1):19-26. PubMed ID: 15075784
[TBL] [Abstract][Full Text] [Related]
15. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
16. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
[TBL] [Abstract][Full Text] [Related]
17. Organized colorectal cancer screening in Serbia - the first round within 2013-2014.
Banković Lazarević D; Krivokapić Z; Barišić G; Jovanović V; Ilić D; Veljković M
Vojnosanit Pregl; 2016 Apr; 73(4):360-7. PubMed ID: 29309104
[TBL] [Abstract][Full Text] [Related]
18. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
[TBL] [Abstract][Full Text] [Related]
20. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
Choi KS; Lee HY; Jun JK; Shin A; Park EC
J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]